<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 154 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page153.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=154">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 154 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 154</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=154"><img src="../thumb/154.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3.10 / 7.4 / 7.4.1                                  2020-04 / 123

                   THE NOAC* YOU AND YOUR PATIENTS CAN RELY ON


                     *NOAC = non-vitamin K oral anticoagulant

       myosit., musc. cramps, periph.oed. Very rare: Stev.-Johns. syndr., tox.  Contra-indications: Liv.funct.impairm., pregn.& lactat, cardiogen.  & phenobarb., act. of BP low.preps.enhanc., reduc.digox.clear., incr.
       epiderm.necrolys., erythema multiforme, rhabdomyolys., myopathy.  shock, uncontrol.HF, sick sinus syndr.incl.sino-atrial block, 2  & 3   rd  plasma conc.of quinidine, clear.decr.by diltiazem, tacrolimus metab.
                                                              nd
       Warnings and pecial precautions: Safety & effic. in childr.not est.,   degree heart block, untreat phaeochromocyt., metabol.acidos., brady-  by cytochrome P450 3A4, exacerbat.of other concom.antihypertens.
       heart fail., imp.hepat.funct., monit. liv. funct.bef.& dur.treatm., reduc.  card.(&lt;50 b/p/m), bronchosp.& bronch. asthma hist., hypotens., sev.
       dos./ discont. ther.if ALT/AST &gt;3xULN persist, heavy alcoh. ingest.,   periph.circulat. disords., verapamil ther., safety & effic.in childr. not est.  ADCO-VASCARD, AI Pharm Ltd [P/S]
       liv.dis.hist., discont.if CPK lev.are mark. elev.or if myopathy is diagn./  Side-effects: CNS effs., GI disturbs., dyspn., oed., bradycard., slow.  Nifedipine.
       susp., pt.to report any musc.pain/-weakn./-tendern./-cramp esp. if   AV conduct./AV block, hypotens., HF, incr.intermitt.claudicat., vis.  Indications: Treatm./prophylax.of chron.stable ang.pect., mild to
       accompan.by malaise & fev., withdr.in ac./ ser. condit.suggest.of a   disturbs., impot., bronchosp., rash, cold/cyanot.extremit., Raynauds,   mod.hypertens
       myopathy/having a risk fact. predispos.to ren.fail.developm.second.  dry eyes, mucocutan.toxic., pneumonit., pleurisy, periph.neuropathy,   (S3) SR CAPS, 32/7.1/0551, 42/7.1/0418
       to rhabdomyolys, predispos.facts.for rhabdomyolys., meas.CPK bef.  revers.alopec., bld.dyscras., metabol.chang.affect. gluc.contr.& chol.  861545-001: 30 mg, 30, R148,11
                                                                  722977-001: 60 mg, 30, R214,52
       init.ther.in ren. imairm. /hypothyroid./ musc.disord.hist./hist.of musc.   conc., lupus like syndr., scleros. peritonit., retroperiton. fibros., sev.
       toxic. with statin or fibrate, liv.dis.hist./substant. alcoh. consumpt.& in   periph.vasc.dis./periph.gangrene poss., psoriasis aggrav., myasth.  Dosage: Init: 30 mg dly. Dos.may be incr.to max. 90 mg dly.depen.
                                                                  on indiv.requirm.
       elderly&gt;70 yrs, do not init. ther if CPK lev.&gt;5xULN at baseline but re-  grav.poss.unmask.
       meas. aft.5-7 days to re-confirm result, do not meas.CPK aft. stren.ex-  Special precautions: Ren.insuff., IV ß-blocks. admin., sens. to al-  Contraindications: Pregn., lactat., CV shock, unstable angina &
       erc./if alternat.cause of CPK incr.poss., cosid. discont.if musc.sympts.  lergens & sev.of anaphylact. reacts.incr., elderly, CHF to be stabilis.  bradycard., HF, ac.MI incl.1st 30 days thereaft., hepat.impairm., GI/
                                                            st
       sev.& cause dly. discomf., discont.if CPK &gt;10xULN or rhabdomyolys.   bef. init. ther., grad.withdr., periph.circulat.disords., 1  degr.heart   oesophag. obstruct./ or hist.thereof, decr.diamet.of GIT lumen, in-
       diagn./ suspect., monit.concom.warfar./digox., concom. cytochrome   block, Prinzmetal’s ang., diabet., hyperthyroid., asthma, bronchit.  flam.bowel dis., very low BP, sev.aort. stenos., concom.rifampicin,
                                                                  not recomm.in childr.
       P450 3A4 inhibit.e.g. cyclospor./ macrolide antibiot./nefazodone/azole   pulm.dis., rebound hypertens.risk incr.aft.sudd.withdr.of chron.clo-
       antifung./& HIV prot.inhibit.  nid., underly. card.disords., phaeochromocyt.req. concom. alpha-  Side effects: Freq: Headache, dizz.,fac. flush., naus., warm feel.
                                                                  Less freq: Trans.blindn.& blurr. vis., tachycard., post.hypotens.,
       Interactions: Atorvastatin: Myopathy risk incr. with concom.cyclo-  adrenorecept.block.ther.
       spor./fibric acid derivat. /erythromyc./ niacin or azole antifung., oral   Drug interactions: Exagg.neg.eff.on contractil.& AV conduct.with   vasodilat., angina, CV disords., periph.oed., epistax., gingiv. hyper-
                                                                  plas., gingivit., constipat., diarrh., dry mouth, anorex., vomit., oe-
       antacids contain Mg & Al decr.plasma conc., plasma conc.decr.with   verapamil/dilitiazem, life-threat. eff.with concom.class I anti-arrythm.,
       colestipol although LDLC reduct. was great.in combin.than when ei-  hypotens. risk incr.& tachycard.reflex atten.with anaesthet., sympa-  sophagit., dsyphag., intestin. obstruct., jaund., abdom.pain, itch., ur-
                                                                  ticar., prurit., exfoliat. dermat., skin rash, tiredn., weakn., asthen., oed.
       ther med was giv.alone, steady-state plasma conc.of digox. poss.incr.,   thicomimet.agents counter ß-block.eff., TCA’s/barbitur.& phenothiaz.
       erythromyc./clarithromycin incr.plasma conc., itraconazole incr.plasma   incr.bld.press.low. eff., oxidat.metabol.of ß-block.delay.by serotonin   Freq.unknown: Leucopen., purpura, anaphylact. reacts., angioed.,
                                                                  allerg.reacts., gynaecomast., hyperglycaem., weight loss, depress.,
       conc., AUC values of norethindrone & ethinyl estradiol incr., cyclo-  reuptake inhibit./other meds.predomin.metabol.by CYPZD6 pathway.  insomn., trem., paraesthes., hypoesthes., nervousn., somnol., eye
       spor./ macrolide antibiot./nefazodone/azole antifung./ & HIV prot.
       inhibit.poss.incr.plasma lev., P-glycoprot. inhibit.poss.incr.bioavail.,   pain, optic.percept. changes, vertigo, palpitat., MI, syncope, cerebr/
                                                                  myocard. ischaem., ischaem.chest pain, dyspn., GI disturbs., exanthe-
       small decr. in prothrombin time dur.first days of dos.with concom.
       warfarin, risk of atorvastatin-induc. myopathy incr.with gemfibrozil/ 7.4   Anti-anginal agents  ma, macupapul.rash, vesicobull.rush, photosens.dermatit., arthralg.,
       fibric acid derivats., incr.risk of myopathy with niacin     (See also 7.3)  myalg., leg cramps, joint disord., polyuria, noctur., dysur., incr.dly.urin.
                                                                  excret., perspirat., lethargy, substern.chst pain, fac.oed., abnorm.LFT.
       LOVISPES, (Ascendis Pharma) Akacia [PWR]                   Warnings and special precautions: Obstruct.GI sympts report.
       Nebivolol                                                  without GI disords./hist.thereof, do not use in pts.with Kock pouch,
       Indications: Mild to mod.essent.hypertens.  7.4.1   Calcium channel    heart disords.as HF poss., monit.BP esp.if on other antihypertens.,
       (S3) TABS, 43/7.1.3/0434                                   sev. hypotens., dialys.pts.with malign.hypertens., sev. aort. stenos.,
       716483-001: 5 mg, 30, R190,49        blockers              irrevers.kidn.fail.with hypovolaem., contr.of diabet.mellit., lact.intol.,
       Dosage: Adults: 5 mg dly.pref.at the same time each day. Ad-  monit.for digox.toxic., safety in pregn.& lactat.not est.
       dit.antihypertens. eff.observ.when combin. with hydrochlorothi-  ADALAT, Bayer [P/S]  Interactions: Poss.enhanc./supplem.ß-block./ diuret.BP low.eff., as
       az.12,5–25 mg.                Nifedipine                   extens.metabol.by cytochrome P450-enzyme syst.interacts.poss.with
       Ren.impairm: Init.2,5 mg dly. Incr.dly.dos.to 5 mg maint.dos.if reqd.  Indications: Chron.stable ang.pect.prophylax., mild to mod.hy-  other meds.shar.same metabol.pathway & enzyme induc., plasma di-
       Pts.over 65 yrs: Init.2,5 mg dly. Incr.dly.dos.to 5 mg maint.dos.if reqd.  pertens.  goxin lev.incr., bioavailabil.reduc. by phenytoin, careful monit.if qui-
       Contraindications: Hepat.impairm., bronchosp. / asthma or ob-  (S3) XL TABS, A39/7.1/0634, Y/7.1/314,315.  nidine/tacrolimus add. to ther.with Adco Vascard & dos.reduc.poss.
       struct.airway dis.hist., metabol. acidos., cardiogen.shock, uncon-  711607-001: 20 mg, 28, R231,16  necess., poss.dos.reduct.with quinupristin/ dalfopristin., eff.potent.by
       trol.HF, sick sinus syndr.incl.sino-atrial block, hypotens., sev.periph.   793124-026: 30 mg, 28, R250,59  cimetidine, effic weak. by rifampicin, dilitiazem decr.clear., grapefruit
       arter.dis., bradycard.(&lt;50 b/p/m), 2  & 3  degree AV block, untreat   793124-018: 60 mg, 28, R332,15  juice inhib. metabol.elev.plasma conc., cisapride & valproic acid incr.
                        rd
                      nd
       phaeochromocyt., verapamil ther., safety & effic.in childr.not est.,   Dosage: Swallow whole with glass of fluid at approx.24 hr.interv.  plasma conc., poss.decr.effic. with carbamazepine & phenobarbitone,
       pregn.& lactat,               pref.in morn. Init.recomm.dos: 30 mg once dly. Incr.if necess.accord.  ADCO-ZILDEM, AI Pharm Ltd [P/S]
       Side effects: Bld.dyscras., angioneurot.oed., hypersens., hypo-/  to indiv. requirem.to max. 90 mg once dly. Titrate over 7-14 days.  Diltiazem HCl.
       hyperglycaem., triglycer.& chol.bld.conc.changes, CNS effs., periph.   Contraindications: Pregn., breastfeed/lactat., CV shock., aort.  Indications: Prophylax.of ang.pect.incl. Prinzmetal’s ang., mild to
       neuropathy, psychos., imp.vis., sore/dry eyes, oculo-mucocutan.toxic.,   stenos., unstab.ang., dur./within 1 mnth.of MI, care in very low BP/  mod.hypertens.
       bradycard., HF, slow.AV conduct./AV block, hypotens., incr.intermitt.   manifest HF, hepat.impairm., GI obstruct hist., oesophag. obstruct.,   (S3) TABS, [P/S] 30/7.1/0287, 0288.
       claudicat., cold extremit., exacerb.periph.vasc.dis., Raynauds syndr.,   decr.diamet.of GI tract lumen, Kock pouch, inflamm.bowel dis., con-  822213-029: 60 mg, 60, R203,22
       post.hypotens., dyspn., bronchosp., pneumonit., pulm.fibros., pleurisy,   com.rifampicin, safety & effic.in childr.und.18 yrs.not est.  824364-007: 90 mg, 60, R466,17
       GI disturbs., prurit., rash, psorias. exacerbat., lupus-like syndr., revers.  Side effects: Allerg./anaphylact.reacts., prurit., urticar., skin rash,   Dosage: Ang.& hypertens: Using 60 mg tabs: 30-60 mg 3-4xdly.,
       alopec., arthralg., myopathy, musc.cramps, impot., tiredn., oed., scle-  anx.reacts., sleep disords., headache, vertigo, migraine, dizzin., trem.,   may be incr.by 30-60 mg increm.in 3-4 div.dos./day. Using 90 mg tabs:
       ros. peritonit., retroperiton.fibros.  somnol., par-/dysaesthesia, eye pain, vis.disturbs., amblyop., tachy-  90-180 mg 2x/day, dos may be incr.by 90 mg increm.in 2 div.dos./day.
       Special precautions: Incr.severity of react.when pt.with an antigen.  card., palpitat., chest pain, oed., vasodilat., hypotens., syncope, nose   (S3) SR CAPS, 30/7.1/0183, 0184.
       anaphylax.hist.is subj.to rep. chall.while on ther., concom.antimalar.,   bleed, nas. congest., GI disturbs., gingiv.hyperplas., trans.liv. enzyme   839183-003: 180 mg, 30, R303,02
       caref. control of digitalisat., hyperthyroid.& hypoglycaem. sympts.  incr., erythema, palpable purpura, musc. cramps, joint swell., arthralg,   839191-006: 240 mg, 30, R304,19
       poss.mask., ren.impairm., elderly, grad. withdr., myasth.grav.poss.  myalg., polyur., dysur., erect.dysfunct., feel.unwell., unspec.pain, chills.   Dosage: To meet pt.needs titrate with an immed. release prepar.&
       unmask., Prinzmetal’s ang., psorias., phaeochromocyt.pts.to receiv.   Post market.: agranulocytos., hyperglycaem., hypoaesthes., dyspn.,   substit.with SR caps.once dly. dos. optimis. Swallow intact with liq.
       concom.alpha adrenocept.block., anaesthes., CHF to be stabilis., pe-  bezoar, dysphag., intestin. obstruct., intestin.ulc., jaund., tox.epiderm.   180 mg (1 cap) 1-2xdly. 240 mg (1 cap) once dly.
       riph.circulat.disords., 1  degr. heart block, COPD.  necrolys., photosens.allerg.react., gynaecomast.  Contraindications: Pregn., women of child bear. age, lactat., decom-
                 st
       Drug interactions: Hypotens.risk incr.& tachycard. reflex atten.  Warnings and special precautions: Grapefruit juice, drugs   pens.card.insuff., sick sinus syndr., conduct.disturbs., bradycard., sev.
       with anaesthet.caus. myocard.depress., antiarrhythm.meds.& meds   known to either inhib./induc. cytochrome P450 3A4 as nifedipine 1   st  liv.& kidn. funct.impairm., porphyr., safety in childr.not est.
       affect. card.conduct.may precipit.bradycard.& heart block, other an-  pass or clear. poss.alter., obstruct.sympts.without known GI disord.  Side effects: GI disturbs., dizzin., confus., headache, erythema mul-
       tihypertens.enhanc. antihypertens. eff., poss.life-threat.conseq.with   hist., combin.with IV Mg.sulph.poss. causes. excess.BP fall, discont.  tiforme, ankle oed., hypotens., bradycard.&lt;55/min, 1st degr.AV-block,
                        ++
       hypoglycaem.agents & phenothiaz., Ca  chann. block. verapamil&   if “steal”eff.exper., do not switch once pt.stabilis.on XL tabs., dialys.   flush., gynaecomast., hyperactiv.with assoc.psych. sympts., hypers-
       diltiazem have result.in hypotens. /bradycard./conduct.defects & HF   pts with malign.hypertens. & irrevers.kidn.fail.with hypovolaem.as   ens., incr.liv.enzymes, hepatit.
       partic. where ventric.funct.imp.&/or SA/AV conduct. abnormalit.pres.,   BP fall poss., ang.pts.with hypotens., HF, sev.aort.stenos., poor card.  Special precautions: Elderly, imp.liv./kidn. funct., decr.dos.in brady-
       poss.card.conduct.defects with antimalar., incr.heart block & brady-  reserve, diabet.mellit.as trans.rise in bld.gluc., poss.false posit. effs.  card.& discont.if persists., pre-exist.hypotens., imp.L ventric.funct.,
       card. risk with digox., sympathomim.may counteract.ß-block.eff.,   with Ba contrast X-ray, consid.if in-vitro fertilizat. rep.unsuccessf.  concom. ß-recept.block./digital.glycosid., anaesthes.
       incr.plasma lev.with subst. inhibit.CYP2D6 isoenzym., TCA’s/barbi-  due to poss.imp.sperm funct., poss.enhanc./supplem.BP low.eff.of   Drug interactions: Poss.synergist.hypotens.in combinat.with alpha
       tur. & phenothiaz.incr.bld. press.low.eff., incr.plasma lev.with cimetid.  ß-blocks. & diuret., BP monit.dur.init.& titrat.esp. with antihypertens.
                                     ther., monit.concom.tacrolimus plasma conc., withdr.grad., does not   block., incr.propranol.ser.lev., inhibit.of digital.glycos.metabol., bld.
       NEBILET, AI Pharm Ltd [PWR]   replace nitroglycerines in ac.attack  lev.of carbamazepine, cyclosporine & theophylline poss incr., incr.
       Nebivolol                     Interactions: Rifampicin weak.effic., poss. incr. plasma conc.with   diltiazem plasma conc.with cimetid.
       Indications: Mild to mod.essent.hypertens.  grapefruit juice/quinupristin/ dalfopristin/cisapride/erythromycin/  AMLOC, Pharma Dynamics (Pty) Ltd
       (S3) TABS, 34/7.1.3/0495      fluoxetine/ amprenavir/indinavir/ritonavir/saquinavir/ nefazodone   See Section 7.3.7
       700558-003: 5 mg, 30, R265,90  & valproic acid, poss.incr.in system. bioavailabil.with ketoconazole/
       Dosage: Adults: 5 mg dly pref.at the same time each day. Addit.  itraconazole & fluconazole, antihypertens.eff.potent.by cimetidine.,   BIO-NIFEDIPINE, Biotech [P/S]
       antihypertens. eff.when combin. with hydrochlorothiaz.12,5–25 mg.  reduc.eff.with phenytoin, poss.decr. plasma conc.with carbamazepine   Nifedipine
                            S4 Pradaxa ® . 110 mg. Each capsule contains 110 mg of dabigatran etexilate base (as mesilate salt). Reg. No. 42/8.2/0131. S4 Pradaxa ® . 150 mg. Each capsule contains 150 mg of dabigatran
                            etexilate base (as mesilate salt). Reg. No. 45/8.2/0162. For full prescribing information refer to the professional information approved by the Regulatory Authority.
                            Applicant details: Ingelheim Pharmaceuticals (Pty) Ltd, 407 Pine Ave, Randburg. Tel: +27 (011) 348-2400. Cpy. Reg. No. 1966/008618/07. BI Ref. No. PC-ZA-100406. Expiry date: August 2021.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page153.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page149.html">149</a>&nbsp;&nbsp;&nbsp;<a href="page150.html">150</a>&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>&nbsp;&nbsp;&nbsp;<a href="page155.html">155</a>&nbsp;&nbsp;&nbsp;<a href="page156.html">156</a>&nbsp;&nbsp;&nbsp;<a href="page157.html">157</a>&nbsp;&nbsp;&nbsp;<a href="page158.html">158</a>&nbsp;&nbsp;&nbsp;<a href="page159.html">159</a>
             </td>
             <td width="35%"><a href="page155.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page155.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
